Accuray Incorporated has received a multi-system order from 21st Century Oncology for one CyberKnife M6 and four TomoHDA Systems. These are the latest generation CyberKnife and TomoTherapy Systems, and are used worldwide to provide extremely precise radiation treatments for cancerous and non-cancerous tumors throughout the body. The TomoTherapy Systems will replace conventional linear accelerators in single vault freestanding centers, reinforcing the TomoTherapy's value as a mainstream radiation therapy device. Accuray booked the order in its first fiscal quarter of 2016.
"This latest transaction by 21st Century is the most recent example of a multiple unit order for Accuray systems," said Joshua H. Levine, president and chief executive officer of Accuray. "Whether clinicians choose to order both the CyberKnife and TomoTherapy Systems or multiple units of a single system, we believe these orders speak to the high degree of flexibility and precision our systems provide and growing market interest in our customer-driven solutions."
21st Century is the largest integrated network of cancer treatment centers and affiliated physicians in the world. The 21st Century network offers a high level of coordinated care from cancer diagnosis through surgery, radiation, and systemic treatment as required. As of June 30, 2015, the company operated 183 treatment centers, including 148 centers located in 17 U.S. states and 35 centers located in six countries in Latin America. 21st Century strives to provide each cancer patient with state-of-the-art treatments that precisely address his or her individual needs. With the new order for the CyberKnife and TomoHDA Systems, 21st Century is supporting this goal, and positively impacting the way cancer treatments are managed at their centers.
For more information: www.accuray.com
March 28, 2024 
